Skip to main content

Biogen Alzheimer's drug exceeds expectations

A Biogen Alzheimer's drug showed reductions in levels of the amyloid plaques and a significant slowing of the disease's hallmark cognitive declines.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.